Grail
Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference
The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent.
Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test
PINC AI plans to adapt its clinical decision support platform to alert clinicians to patients who may benefit from early cancer detection via Galleri.
Illumina is seeing continued strength in its core next-generation sequencing business as the firm is officially bringing Grail on board.
Illumina Q3 Revenues Grow 40 Percent
Following the closing of its purchase of Grail in August, the company is reporting consolidated results as well as separate results for its core business and Grail.
European Commission Adopts Interim Measure to Hold Grail Separate From Illumina
The measures are legally binding for both Illumina and Grail, and compliance with them will be monitored by a trustee to be approved by the commission.
Aug 19, 2021
Jul 21, 2021
Apr 15, 2021
Mar 31, 2021
Illumina Upgraded to Buy by Canaccord Genuity
Mar 30, 2021
FTC Moves to Block Illumina's $8B Grail Acquisition
Jan 11, 2021